Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 231

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 231
---
Class F Common Stock Warrants

On December 3, 2024 in connection with the Class
E Warrant Inducement, (see Note 5), the Company issued Class F Common Stock Warrants to purchase up to shares of common stock
at an initial exercise price of $ per share. The Class F Warrants have an alternative cashless exercise provision that allows the
holder to receive shares of common stock without payment of the exercise price. The Company valued the Class F Common Stock Warrants
on the issuance date, based on the alternative cashless exercise provision, at $ million, which was included in the issuance costs
of the warrant inducement and are treated as equity. The Class F Common Stock Warrants are exercisable for a period of from
, which was the date of shareholder approval. As of March 31, 2025, the Company received alternative cashless exercise
notices for Class F Common Stock Warrants resulting in the issuance of shares of common stock, with Class F Common
Stock Warrants outstanding.

Class G Common Stock Warrants

On December 3, 2024 in connection with the Class
E Warrant Inducement (see Note 5), the Company issued Class G Common Stock Warrants to purchase up to shares of common stock at
an initial exercise price of $ per share, valued on the issuance date in the aggregate at $ million, which was included in the
issuance costs of the warrant inducement and are treated as equity. The Class G Common Stock Warrants are exercisable for a period of
from , which was the date of shareholder approval. As part of the reverse stock split on January 28, 2025,
common stock underlying the Class G Common Stock Warrants was adjusted from shares of common stock to shares of common
stock and the exercise price was reset from $ to $.

The fair value of the Class G Common Stock Warrants
were estimated using the Black-Scholes option pricing model with the following assumptions:

| Volatility              |     |  100 | % |
| Expected term (years)   |     |    5 |   |
| Risk-free interest rate |     | 4.38 | % |
| Expected dividend yield |     |  0.0 | % |

10. Income Taxes The quarterly provision for or benefit from income taxes is computed based upon the estimated annual effective tax rate and the year-to-date pre-tax loss and other comprehensive loss. The Company did not record a